Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » VISXs reliance on sales in international markets could negatively impact its revenues and operating results.

This excerpt taken from the EYE 8-K filed Jul 13, 2005.

VISX’s reliance on sales in international markets could negatively impact its revenues and operating results.

 

Sales to customers outside the United States represented 16%, 17% and 23% of VISX’s total revenues in 2004, 2003 and 2002, respectively, and 17% and 14% for the quarters ended March 31, 2005 and 2004, respectively. To date, all of VISX’s sales have been denominated in United States dollars. VISX’s international presence exposes it to risks, including:

 

· the need for export licenses in many countries;

 

· unexpected regulatory requirements;

 

· tariffs and other potential trade barriers and restrictions;

 

· political, legal and economic instability in foreign markets such as South Korea;

 

· longer accounts receivable cycles in all international markets;

 

· difficulties in managing operations across disparate geographic areas;

 

24

· foreign currency fluctuations;

 

· reduced or limited protection of VISX’s intellectual property rights in some countries such as Taiwan; and

 

· dependence on local distributors.

 

VISX is particularly susceptible to these risks in South Korea, Taiwan and Canada. If one or more of these risks materialize, VISX’s sales to international customers may decrease and VISX’s costs may increase, which could negatively impact VISX’s revenues and operating results.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki